Changes this week
Changes detected in the 7 days to Nov 20, 2026
- Notable: Multi-target TMS for Schizophrenia Negative Symptoms Start date pushed from Oct 1, 2026 to Dec 1, 2026
- Notable: Therapeutically Alternatives In Ventilator-Induced Diaphragm Dysfunction Critically Ill Patients Primary completion date changed from estimate of Oct 1, 2024 to Sep 1, 2025
- Notable: Honest Open Proud for Psychotic and Bipolar Disorder in Norway Primary completion date changed from estimate of Dec 31, 2024 to Oct 30, 2026
- Notable: Sprint Interval Training on Field Hockey Players Primary completion date changed from estimate of Jul 15, 2024 to Aug 25, 2026
- Notable: Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms Enrollment increased: 55 → 120 participants
- Notable: Pain, Central Sensitization, and Misophonia in Lipedema Start date pushed from Sep 28, 2026 to Nov 19, 2026
- Notable: Application of the J-PET Scanner Prototype Study completion date changed from estimate of Oct 30, 2025 to Jun 7, 2026
- Notable: Decode the Environment Variation of Targeted Aldosterone Inducer and siLencer Start date pushed from Oct 10, 2026 to Dec 10, 2026
- Notable: Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence Results posted: Nov 20, 2026
- Notable: Roybal Via Habit Formation Start date pushed from Oct 1, 2026 to Jan 15, 2027
- Notable: Risk Factors and Outcomes of Hepatitis A in Children Start date pushed from Sep 26, 2026 to Nov 26, 2026
- Notable: Disease Outcomes and Toxicities · Gastrointestinal and Sarcomatous Malignancies Enrollment increased: 180 → 450 participants
- Notable: Targeted Therapy to Increase RAI Uptake in Metastatic DTC Primary completion moved earlier from Feb 1, 2031 to Jul 2027
- Notable: Mobile App, AI Chatbot, and Printed Materials to Improve Parents' Dental Trauma Knowledge and Emergency Decisions Eligibility criteria changed
- Notable: Paraffin Wax on Joint Contractures Start date pushed from Oct 2026 to Feb 1, 2027
- Notable: Empowered Relief for Severe Pain After Cesarean Delivery During the Inpatient Period Start date pushed from Oct 5, 2026 to Nov 30, 2026
- Notable: Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder Enrollment reduced: 180 → 120 participants
- Notable: Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Enrollment reduced: 1944 → 1117 participants
- Notable: Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer Enrollment reduced: 1760 → 1150 participants
- Notable: Effects and Safety of CT-P51 and Keytruda · Previously Untreated Metastatic Lung Cancer Primary endpoint(s) modified
- Notable: Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis Results posted: Nov 19, 2026
- Notable: Outcomes of Efgartigimod PH20 SC · New-onset Generalized Myasthenia Gravis (gMG) Primary endpoint(s) modified
- Notable: SOA101 · Advanced Solid Tumors Primary endpoint(s) modified
- Notable: NEROFE, a Novel Hormone-Peptide · Advanced MDS and AML Primary completion pushed from Jun 30, 2025 to Dec 31, 2027
- Notable: External Electrical Stimulation for Male Incontinence Results posted: Nov 19, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates